Literature DB >> 9059987

GABA agonists and neurotransmitters metabolizing enzymes in steroid-primed OVX rats.

G Kaur1, P Sharma, S Bhardwaj, G Kaur1.   

Abstract

The effect of intraventricular (IVT) administration of GABAA receptor agonist muscimol and GABAB receptor agonist, baclofen was examined on the activity of acetylcholinesterase (AChE), monoamine oxidase (MAO) and Na+, K(+)-ATPase in discrete areas of brain from estrogen-progesterone primed ovariectomized rats. AChE enzyme activity was increased in two subcellular fractions (soluble and total particulate) studied, with statistically significant changes in cerebral hemispheres (CH), cerebellum (CB), thalamus (TH) and hypothalamus (HT), Na+, K(+)-ATPase enzyme activity was decreased in both these fractions. MAO activity increased significantly in CH, TH and HT. The presented results suggest a functional relationship between GABAergic (inhibitory), cholinergic and monoaminergic (excitatory) systems by affecting the rate of degradation of the excitatory neurotransmitters and Na+, K(+)-ATPase.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9059987     DOI: 10.1023/a:1006876718783

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  20 in total

1.  GABA: a dominant neurotransmitter in the hypothalamus.

Authors:  C Decavel; A N Van den Pol
Journal:  J Comp Neurol       Date:  1990-12-22       Impact factor: 3.215

2.  Acetylcholine-dopamine balance in striatum: is it still a target for antiparkinsonian therapy?

Authors:  P Calabresi; A Stefani; N B Mercuri; G Bernardi
Journal:  EXS       Date:  1989

3.  gamma-Aminobutyric acid (GABA) receptor stimulation. III. Effect of progabide (SL 76002) on norepinephrine, dopamine and 5-hydroxytryptamine turnover in rat brain areas.

Authors:  B Scatton; B Zivkovic; J Dedek; K G Lloyd; J Constantinidis; R Tissot; G Bartholini
Journal:  J Pharmacol Exp Ther       Date:  1982-03       Impact factor: 4.030

4.  On the relationship between noradrenergic stimulatory and GABAergic inhibitory systems in the control of luteinizing hormone secretion in female rats.

Authors:  T Akema; A Chiba; F Kimura
Journal:  Neuroendocrinology       Date:  1990-12       Impact factor: 4.914

5.  Differential effects of GABAA and GABAB receptor agonists on NMDA-induced and noradrenaline-induced luteinizing-hormone release in the ovariectomized estrogen-primed rat.

Authors:  T Akema; F Kimura
Journal:  Neuroendocrinology       Date:  1993-01       Impact factor: 4.914

6.  Evidence for gamma-aminobutyric acid modulation of ovarian hormonal effects on luteinizing hormone secretion and hypothalamic catecholamine activity in the female rat.

Authors:  B A Adler; W R Crowley
Journal:  Endocrinology       Date:  1986-01       Impact factor: 4.736

7.  GABAergic modulation of striatal cholinergic interneurons: an in vivo microdialysis study.

Authors:  P DeBoer; B H Westerink
Journal:  J Neurochem       Date:  1994-01       Impact factor: 5.372

8.  Changes in monoamine oxidase activity in rat brain during alloxan diabetes.

Authors:  C S Mayanil; S M Kazmi; N Z Baquer
Journal:  J Neurochem       Date:  1982-01       Impact factor: 5.372

9.  GABA receptor mediation of median preoptic nucleus-evoked inhibition of supraoptic neurosecretory neurones in rat.

Authors:  R Nissen; L P Renaud
Journal:  J Physiol       Date:  1994-09-01       Impact factor: 5.182

10.  Lower brainstem afferents to the cat posterior hypothalamus: a double-labeling study.

Authors:  K Sakai; Y Yoshimoto; P H Luppi; P Fort; M el Mansari; D Salvert; M Jouvet
Journal:  Brain Res Bull       Date:  1990-03       Impact factor: 4.077

View more
  2 in total

1.  Role of cholinergic and GABAergic neurotransmission in the opioids-mediated GnRH release mechanism of EBP-primed OVX rats.

Authors:  G Kaur; G Kaur
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

2.  N-myc downstream-regulated gene 2, a novel estrogen-targeted gene, is involved in the regulation of Na+/K+-ATPase.

Authors:  Yan Li; Jiandong Yang; Shaoqing Li; Jian Zhang; Jin Zheng; Wugang Hou; Huadong Zhao; Yanyan Guo; Xinping Liu; Kefeng Dou; Zhenqiang Situ; Libo Yao
Journal:  J Biol Chem       Date:  2011-07-19       Impact factor: 5.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.